BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17249651)

  • 1. New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells.
    Middleton RJ; Briddon SJ; Cordeaux Y; Yates AS; Dale CL; George MW; Baker JG; Hill SJ; Kellam B
    J Med Chem; 2007 Feb; 50(4):782-93. PubMed ID: 17249651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Romagnoli R; Preti D; Bovero A; Pineda de Las Infantas MJ; Moorman A; Varani K; Borea PA
    J Med Chem; 2004 Oct; 47(22):5535-40. PubMed ID: 15481989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
    Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A(2A) receptor agonist and adenosine A(3) receptor antagonist activity.
    Bevan N; Butchers PR; Cousins R; Coates J; Edgar EV; Morrison V; Sheehan MJ; Reeves J; Wilson DJ
    Eur J Pharmacol; 2007 Jun; 564(1-3):219-25. PubMed ID: 17382926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor.
    Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Roerink SF; van den Hout G; Beukers MW; Brussee J; Ijzerman AP
    J Med Chem; 2005 Mar; 48(6):2045-53. PubMed ID: 15771447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
    Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ
    Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice.
    Franchetti P; Cappellacci L; Vita P; Petrelli R; Lavecchia A; Kachler S; Klotz KN; Marabese I; Luongo L; Maione S; Grifantini M
    J Med Chem; 2009 Apr; 52(8):2393-406. PubMed ID: 19317449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-occupied A3 adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells.
    Cordeaux Y; Briddon SJ; Alexander SP; Kellam B; Hill SJ
    FASEB J; 2008 Mar; 22(3):850-60. PubMed ID: 17959910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
    Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
    J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligands.
    Baker JG; Middleton R; Adams L; May LT; Briddon SJ; Kellam B; Hill SJ
    Br J Pharmacol; 2010 Feb; 159(4):772-86. PubMed ID: 20105183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid ortho/allosteric ligands for the adenosine A(1) receptor.
    Narlawar R; Lane JR; Doddareddy M; Lin J; Brussee J; Ijzerman AP
    J Med Chem; 2010 Apr; 53(8):3028-37. PubMed ID: 20345101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of fluorescence correlation spectroscopy to the measurement of agonist binding to a G-protein coupled receptor at the single cell level.
    Briddon SJ; Middleton RJ; Yates AS; George MW; Kellam B; Hill SJ
    Faraday Discuss; 2004; 126():197-207; discussion 245-54. PubMed ID: 14992407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-substituted C5'-modified adenosines as A1 adenosine receptor agonists.
    Ashton TD; Baker SP; Hutchinson SA; Scammells PJ
    Bioorg Med Chem; 2008 Feb; 16(4):1861-73. PubMed ID: 18042389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
    Beukers MW; Wanner MJ; Von Frijtag Drabbe Künzel JK; Klaasse EC; IJzerman AP; Koomen GJ
    J Med Chem; 2003 Apr; 46(8):1492-503. PubMed ID: 12672250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]- 9H-purin-9-yl]-N-ethyl-beta-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonists.
    Baraldi PG; Preti D; Tabrizi MA; Fruttarolo F; Romagnoli R; Carrion MD; Cara LC; Moorman AR; Varani K; Borea PA
    J Med Chem; 2007 Jan; 50(2):374-80. PubMed ID: 17228880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly potent and selective fluorescent antagonists of the human adenosine A₃ receptor based on the 1,2,4-triazolo[4,3-a]quinoxalin-1-one scaffold.
    Vernall AJ; Stoddart LA; Briddon SJ; Hill SJ; Kellam B
    J Med Chem; 2012 Feb; 55(4):1771-82. PubMed ID: 22277057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence microscopy investigations of ligand propagation and accessibility under adherent cells.
    Swift JL; Sergeev M; Wiseman PW
    Biointerphases; 2010 Dec; 5(4):139-48. PubMed ID: 21219035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioligand binding and functional responses of ligands for human recombinant adenosine A(3) receptors.
    Yates L; Clark JH; Martin TJ; James S; Broadley KJ; Kidd EJ
    Auton Autacoid Pharmacol; 2006 Apr; 26(2):191-200. PubMed ID: 16553647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel amino acid derived natural products from the ascidian Atriolum robustum: identification and pharmacological characterization of a unique adenosine derivative.
    Kehraus S; Gorzalka S; Hallmen C; Iqbal J; Müller CE; Wright AD; Wiese M; König GM
    J Med Chem; 2004 Apr; 47(9):2243-55. PubMed ID: 15084123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A3 receptor.
    Volpini R; Buccioni M; Dal Ben D; Lambertucci C; Lammi C; Marucci G; Ramadori AT; Klotz KN; Cristalli G
    J Med Chem; 2009 Dec; 52(23):7897-900. PubMed ID: 19839592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.